Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

Your search for ‘Smart & Biggar’ returned 2,497 results

Use advanced search filters to refine your search

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    List Of Generic Submissions Under Review Now Available

    As previously reported, Health Canada had advised that beginning on October 1, 2018, it would implement certain proposals for its prescription drug product transparency initiatives.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    CETA Receives Approval - What IP Owners Need To Know

    The primary goal of CETA is to eliminate or reduce tariffs on trade between Canada and the EU and the harmonization of other rules to encourage trade.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
Article

Recent .ca Domain Name Decision Accepts Broad Interpretation Of What Constitutes A Brand Owner’s Prior Trade-Mark "Rights" In Canada

The recent decision of Guitar Center Inc v Robert Piperni ("Guitar Center"), CIRA Decision No. 0254, confirms that a broad definition of "rights" should apply to brand owners seeking to prove prior trade-mark rights in Canada.
CanadaIntellectual Property
Smart & Biggar
Smart & Biggar
  • Article

    Competition Bureau Proves Drip Pricing Is A Hot Button Topic

    The Competition Bureau demonstrated its commitment to enforcing against the practice of drip pricing or hidden fees with its October 28, 2019 announcement of its investigation into FlightHub Group Inc
    CanadaAntitrust/Competition Law
    Smart & Biggar
    Smart & Biggar
  • Article

    Canada's Drug Agency Announces Consultation On Streamlined Review Process And New Reconsideration/resubmission Procedures

    On January 29, 2026, Canada's Drug Agency (CDA) published Improvements to the Drug Reimbursement Review Process, which includes a section for consultation on proposed changes to the reimbursement review process.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Cannabis Litigation Update: United Cannabis Corp v Pure Hemp Collective Inc.

    Last September, before the new world of legalized recreational cannabis had opened-up in Canada, we reported on the state of IP litigation in the cannabis industry.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    PMPRB Adopts Amended Interim Guidance Pending Release Of New Guidelines

    As previously reported, the Patented Medicine Prices Review Board (PMPRB) proposed amendments in June 2023 to its Interim Guidance ("Amended Interim Guidance")...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    PMPRB Announces Anie Perrault As Acting Chairperson And Releases Latest Expenditure Report On Private Drug Plan Costs And Utilization

    On March 6, 2025, the Patented Medicine Prices Review Board (PMPRB) announced that Thomas Digby stepped down from his role as Chairperson of the PMPRB.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    PMPRB Releases 2020 Annual Report And April 2022 NEWSletter

    On March 30, 2022, the Minister of Health tabled the 2020 Annual Report of the Patented Medicine Prices Review Board.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    PMPRB Releases May NEWSLetter And Meds Pipeline Monitor

    On May 12, 2026, the Patented Medicine Prices Review Board (PMPRB) released its May NEWSLetter. The NEWSletter provides updates on the implementation of the new Guidelines for PMPRB Staff, the consultation of the proposed Hearing Practice Directions, events in which the PMPRB participated, and new and upcoming NPDUIS research publications.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    PMPRB Update: Guidelines For PMPRB Staff Come Into Effect January 1, 2026; 2024 Annual Report

    On January 1, 2026, the Guidelines for PMPRB Staff will come into effect. In November, the Patented Medicine Prices Review Board (PMPRB) held information sessions on...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Summary Of Various COVID-19 Measures Instituted By Health Canada

    Health Canada has instituted numerous measures to help address and combat COVID-19, from facilitating access to COVID-19 products to protecting the public from false ...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Bereskin & Parr Webinar: "Promises, Promises" – Register Now

    Our panel will discuss the implications of the decision on patent drafting, prosecution and litigation.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Canada Releases Statement On Implementation For The Comprehensive And Progressive Agreement For Trans-Pacific Partnership (CPTPP)

    On October 17, 2020, the Government of Canada published a Statement on Implementation for the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP) (the "Statement").
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Europe's Unitary Patent Has Arrived!

    Today, the German government ratified the Unified Patent Court Agreement (UPCA), setting in motion significant changes to the patent system in Europe.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Extended Protection For Published Sound Recordings And Performances Fixed In Sound Recordings Now In Force

    The extended term of protection also does not have the effect of reviving copyright or rights to remunerations that expired prior to June 23, 2015.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    It’s Not Easy Being Green: FTC Issues New Green Guides In The U.S.

    In October 2012, the U.S. Federal Trade Commission released new Green Guides.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Proposed Legislation For Patent Term Adjustment, And The Interplay With CSPs

    Bill C-47, "An Act to implement certain provisions of the budget tabled in Parliament on March 28, 2023," aka "Budget Implementation Act, 2023, No. 1" is an omnibus bill that includes proposed amendments...
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Supreme Court Of Canada Leave Applications - May 2020

    As previously reported, the Federal Court of Appeal (FCA) dismissed Pfizer's appeal from a decision granting Pharmascience's motion for a summary trial on Pfizer's defence of ex turpi causa...
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    New Signage Law In Québec - Brand Owners: Get Ready To Add French To Your Signage

    In a press release yesterday, the Québec Government announced that the proposed amendments to the Regulations under the Charter of the French Language will come into force on November 24, 2016.
    CanadaMedia, Telecoms, IT, Entertainment
    Smart & Biggar
    Smart & Biggar
  • Showing 341–360 of 2497 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics